{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:05:19Z","timestamp":1785351919174,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004152","name":"Macao Polytechnic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004152","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.compbiolchem.2024.108224","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T21:37:28Z","timestamp":1727473048000},"page":"108224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The multiple-action allosteric inhibition of TYK2 by deucravacitinib: Insights from computational simulations"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8835-0587","authenticated-orcid":false,"given":"Yiqiong","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4632-4364","authenticated-orcid":false,"given":"Jingjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.compbiolchem.2024.108224_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108224_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20140712","article-title":"The molecular regulation of Janus kinase (JAK) activation","volume":"462","author":"Babon","year":"2014","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.compbiolchem.2024.108224_bib3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nsmb.2348","article-title":"Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F","volume":"19","author":"Bandaranayake","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.compbiolchem.2024.108224_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/ps.7699","article-title":"Allosteric inhibition of myosin by phenamacril: a synergistic mechanism revealed by computational and experimental approaches","author":"Bao","year":"2023","journal-title":"Pest Manag. Sci."},{"issue":"20","key":"10.1016\/j.compbiolchem.2024.108224_bib5","doi-asserted-by":"crossref","first-page":"14335","DOI":"10.1021\/acs.jmedchem.3c01373","article-title":"Targeting the Tyrosine Kinase 2 (TYK2) pseudokinase domain: discovery of the selective TYK2 inhibitor ABBV-712","volume":"66","author":"Breinlinger","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108224_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw1736","article-title":"Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain","volume":"11","author":"Burke","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.compbiolchem.2024.108224_bib7","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108224_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/cts.13435","article-title":"First-in-human study of deucravacitinib: a\u00a0selective, potent, allosteric small-molecule inhibitor of tyrosine kinase 2","volume":"16","author":"Catlett","year":"2023","journal-title":"Clin. Transl. Sci."},{"issue":"3","key":"10.1016\/j.compbiolchem.2024.108224_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112201","article-title":"Structural basis of Janus kinase trans-activation","volume":"42","author":"Caveney","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.compbiolchem.2024.108224_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01299-7","article-title":"A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways","volume":"21","author":"Chen","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"5","key":"10.1016\/j.compbiolchem.2024.108224_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.molcel.2007.06.028","article-title":"A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases","volume":"27","author":"Chen","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.compbiolchem.2024.108224_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110434","article-title":"Recent progress on tyrosine kinase 2 JH2 inhibitors","volume":"121","author":"Deng","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"22","key":"10.1016\/j.compbiolchem.2024.108224_bib13","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1093\/bioinformatics\/bts546","article-title":"NetworkView: 3D display and analysis of protein\u00b7RNA interaction networks","volume":"28","author":"Eargle","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiolchem.2024.108224_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115611","article-title":"Discovery of WD-890: A novel allosteric TYK2 inhibitor for the treatment of multiple autoimmune diseases","volume":"167","author":"Fang","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"34","key":"10.1016\/j.compbiolchem.2024.108224_bib15","doi-asserted-by":"crossref","first-page":"20494","DOI":"10.1074\/jbc.271.34.20494","article-title":"Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase","volume":"271","author":"Gauzzi","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.compbiolchem.2024.108224_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.compbiolchem.2024.108224_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2217\/imt-2021-0096","article-title":"TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases","volume":"13","author":"Gonciarz","year":"2021","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108224_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/13543776.2022.2026927","article-title":"Selective TYK2 inhibitors as potential therapeutic agents: a patent review (2019-2021)","volume":"32","author":"Gonzalez Lopez de Turiso","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.compbiolchem.2024.108224_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18249","article-title":"Allosteric activation of SENP1 by SUMO1 beta-grasp domain involves a dock-and-coalesce mechanism","volume":"5","author":"Guo","year":"2016","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108224_bib20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00894-011-1159-4","article-title":"The molecular basis of IGF-II\/IGF2R recognition: a combined molecular dynamics simulation, free-energy calculation and computational alanine scanning study","volume":"18","author":"Guo","year":"2012","journal-title":"J. Mol. Model"},{"issue":"11","key":"10.1016\/j.compbiolchem.2024.108224_bib21","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.bcp.2006.04.013","article-title":"Jaks and cytokine receptors\u2014an intimate relationship","volume":"72","author":"Haan","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108224_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/13543776.2019.1567713","article-title":"Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015-2018)","volume":"29","author":"He","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"issue":"17","key":"10.1016\/j.compbiolchem.2024.108224_bib23","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s40265-022-01796-y","article-title":"Deucravacitinib: first approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.compbiolchem.2024.108224_bib24","doi-asserted-by":"crossref","first-page":"17783","DOI":"10.1073\/pnas.0607656103","article-title":"Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism","volume":"103","author":"Kornev","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.compbiolchem.2024.108224_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cyto.2015.10.015","article-title":"Tyrosine kinase 2 - Surveillant of tumours and bona fide oncogene","volume":"89","author":"Leitner","year":"2017","journal-title":"Cytokine"},{"issue":"17","key":"10.1016\/j.compbiolchem.2024.108224_bib26","doi-asserted-by":"crossref","first-page":"i781","DOI":"10.1093\/bioinformatics\/bty556","article-title":"Insights on the alteration of functionality of a tyrosine kinase 2 variant: a molecular dynamics study","volume":"34","author":"Lesgidou","year":"2018","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.compbiolchem.2024.108224_bib27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acschemneuro.0c00633","article-title":"Deciphering the T790M\/L858R-selective inhibition mechanism of an allosteric inhibitor of EGFR: insights from molecular simulations","volume":"12","author":"Li","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108224_bib28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/cbdd.14033","article-title":"Insights into the negative regulation of EGFR upon the binding of an allosteric inhibitor","volume":"99","author":"Li","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"issue":"21","key":"10.1016\/j.compbiolchem.2024.108224_bib29","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1021\/acs.jcim.1c00471","article-title":"Molecular mechanism of Ca2+ in the allosteric regulation of human parathyroid hormone receptor-1","volume":"62","author":"Li","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108224_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/ct400751u","article-title":"Taking into account the ion-induced dipole interaction in the nonbonded model of ions","volume":"10","author":"Li","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.compbiolchem.2024.108224_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejmech.2013.03.070","article-title":"Lead identification of novel and selective TYK2 inhibitors","volume":"67","author":"Liang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.compbiolchem.2024.108224_bib32","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1073\/pnas.1401180111","article-title":"Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition","volume":"111","author":"Lupardus","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.compbiolchem.2024.108224_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13671","article-title":"Novel mutations of TYK2 leading to divergent clinical phenotypes","volume":"33","author":"Lv","year":"2021","journal-title":"Pediatr. Allergy Immunol."},{"issue":"8","key":"10.1016\/j.compbiolchem.2024.108224_bib34","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"issue":"9","key":"10.1016\/j.compbiolchem.2024.108224_bib35","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/jcc.10262","article-title":"Development of polyphosphate parameters for use with the AMBER force field","volume":"24","author":"Meagher","year":"2003","journal-title":"J. Comput. Chem."},{"issue":"45","key":"10.1016\/j.compbiolchem.2024.108224_bib36","doi-asserted-by":"crossref","first-page":"27261","DOI":"10.1074\/jbc.M115.672048","article-title":"Structural and functional characterization of the JH2 pseudokinase domain of JAK family tyrosine kinase 2 (TYK2)","volume":"290","author":"Min","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.compbiolchem.2024.108224_bib37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbapap.2015.03.009","article-title":"The ABC of protein kinase conformations","volume":"1854","author":"M\u00f6bitz","year":"2015","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Proteins Proteom."},{"key":"10.1016\/j.compbiolchem.2024.108224_bib38","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1073\/pnas.88.24.11349","article-title":"Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family","volume":"88","author":"Murakami","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.compbiolchem.2024.108224_bib39","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J. Immunol."},{"issue":"50","key":"10.1016\/j.compbiolchem.2024.108224_bib40","doi-asserted-by":"crossref","first-page":"15460","DOI":"10.1021\/acs.jpcb.5b10423","article-title":"Force field for Mg2+, Mn2+, Zn2+, and Cd2+ ions that have balanced interactions with nucleic acids","volume":"119","author":"Panteva","year":"2015","journal-title":"J. Phys. Chem. B"},{"issue":"4","key":"10.1016\/j.compbiolchem.2024.108224_bib41","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1091\/mbc.e02-06-0342","article-title":"Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain","volume":"14","author":"Saharinen","year":"2003","journal-title":"Mol. Biol. Cell"},{"issue":"7","key":"10.1016\/j.compbiolchem.2024.108224_bib42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nsmb.2849","article-title":"Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase","volume":"21","author":"Shan","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.compbiolchem.2024.108224_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00543","article-title":"A Bcr-Abl inhibitor GNF-2 attenuates inflammatory activation of glia and chronic pain","volume":"10","author":"Song","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.compbiolchem.2024.108224_bib44","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41557-018-0077-9","article-title":"Towards simple kinetic models of functional dynamics for a kinase subfamily","volume":"10","author":"Sultan","year":"2018","journal-title":"Nat. Chem."},{"issue":"7","key":"10.1016\/j.compbiolchem.2024.108224_bib45","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/2159-8290.CD-18-0903","article-title":"Single and dual targeting of mutant EGFR with an allosteric inhibitor","volume":"9","author":"To","year":"2019","journal-title":"Cancer Discov."},{"issue":"17","key":"10.1016\/j.compbiolchem.2024.108224_bib46","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1074\/jbc.M114.619502","article-title":"Tyrosine Kinase 2-mediated signal transduction in T lymphocytes is blocked by pharmacological stabilization of its pseudokinase domain","volume":"290","author":"Tokarski","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"38","key":"10.1016\/j.compbiolchem.2024.108224_bib47","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1021\/jacs.9b06064","article-title":"How electrostatic coupling enables conformational plasticity in a tyrosine kinase","volume":"141","author":"Tsai","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108224_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/prot.22889","article-title":"A new regulatory switch in a JAK protein kinase","volume":"79","author":"Tsui","year":"2010","journal-title":"Protein.: Struct., Funct., Bioinforma."},{"issue":"9","key":"10.1016\/j.compbiolchem.2024.108224_bib49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nsmb.2099","article-title":"The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling","volume":"18","author":"Ungureanu","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"2","key":"10.1016\/j.compbiolchem.2024.108224_bib50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/BJ20131516","article-title":"Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses","volume":"458","author":"Varghese","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.compbiolchem.2024.108224_bib51","article-title":"Triple-action inhibitory mechanism of allosteric TYK2-specific inhibitors","author":"Wang","year":"2023","journal-title":"bioRxiv"},{"issue":"20","key":"10.1016\/j.compbiolchem.2024.108224_bib52","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/acs.jmedchem.9b00444","article-title":"Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the treatment of autoimmune diseases: discovery of the allosteric inhibitor BMS-986165","volume":"62","author":"Wrobleski","year":"2019","journal-title":"J. Med Chem."},{"key":"10.1016\/j.compbiolchem.2024.108224_bib53","first-page":"1","article-title":"Unraveling the atomic mechanisms underlying glyphosate insensitivity in EPSPS: implications of distal mutations","author":"Xu","year":"2024","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124002123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124002123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:03:45Z","timestamp":1734015825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927124002123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":53,"alternative-id":["S1476927124002123"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108224","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multiple-action allosteric inhibition of TYK2 by deucravacitinib: Insights from computational simulations","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108224"}}